Screener / Oncology Genomics / Exelixis Inc

EXEL · NASDAQ

Exelixis Inc

Compliant

Under AAOIFI Standard 21, Exelixis Inc is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

TickerEXEL
ExchangeNASDAQ
SectorOncology Genomics

Full ratios for Exelixis Inc (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Exelixis Inc or any other security.